These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20594607)

  • 1. In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry.
    Roldan-Valadez E; Favila R; Martínez-López M; Uribe M; Ríos C; Méndez-Sánchez N
    J Hepatol; 2010 Oct; 53(4):732-7. PubMed ID: 20594607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of intrahepatic triglyceride stores by 1H magnetic resonance spectroscopy: study with rat models and in patients].
    Liu M; Gao X; Rao SX; Wu L; Zeng MS
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):531-3. PubMed ID: 18649768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging.
    Borra RJ; Salo S; Dean K; Lautamäki R; Nuutila P; Komu M; Parkkola R
    Radiology; 2009 Jan; 250(1):130-6. PubMed ID: 19017926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
    Cowin GJ; Jonsson JR; Bauer JD; Ash S; Ali A; Osland EJ; Purdie DM; Clouston AD; Powell EE; Galloway GJ
    J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR fat fraction mapping: a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients.
    Leitão HS; Paulino C; Rodrigues D; Gonçalves SI; Marques C; Carvalheiro M; Geraldes CF; Caseiro-Alves F
    Acad Radiol; 2013 Aug; 20(8):957-61. PubMed ID: 23830602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
    Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
    Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5T in rats with nonalcoholic fatty liver disease.
    Hijona E; Sánchez-González J; Alústiza JM; Hijona L; Arenas J; García E; Rojas N; Portillo MP; Jiménez R; Aldazabal P; Bujanda L
    Eur J Radiol; 2012 Jun; 81(6):1122-7. PubMed ID: 21459536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
    van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
    Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive assessment of hepatic triglyceride content in humans with 13C nuclear magnetic resonance spectroscopy.
    Petersen KF; West AB; Reuben A; Rothman DL; Shulman GI
    Hepatology; 1996 Jul; 24(1):114-7. PubMed ID: 8707248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating childhood obesity: magnetic resonance-based quantification of abdominal adipose tissue and liver fat in children.
    Raschpichler MC; Sorge I; Hirsch W; Mende M; Sergeyev E; Kruber D; Koerner A; Schick F
    Rofo; 2012 Apr; 184(4):324-32. PubMed ID: 22322443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduced insulin effect in subclinical fatty liver].
    Thamer C; Machann J; Haap M; Bachmann O; Wietek B; Dahl D; Tschritter O; Fritsche A; Jacob S; Schick F; Stumvoll M; Häring H
    Dtsch Med Wochenschr; 2004 Apr; 129(16):872-5. PubMed ID: 15083407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (1)H MRS assessment of hepatic steatosis in overweight children and adolescents: comparison between 3T and open 1T MR-systems.
    Chabanova E; Bille DS; Thisted E; Holm JC; Thomsen HS
    Abdom Imaging; 2013 Apr; 38(2):315-9. PubMed ID: 22736224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy.
    Marsman HA; van Werven JR; Nederveen AJ; Ten Kate FJ; Heger M; Stoker J; van Gulik TM
    J Magn Reson Imaging; 2010 Jul; 32(1):148-54. PubMed ID: 20578022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
    McPherson S; Jonsson JR; Cowin GJ; O'Rourke P; Clouston AD; Volp A; Horsfall L; Jothimani D; Fawcett J; Galloway GJ; Benson M; Powell EE
    J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2* relaxation effects.
    Kühn JP; Evert M; Friedrich N; Kannengiesser S; Mayerle J; Thiel R; Lerch MM; Dombrowski F; Mensel B; Hosten N; Puls R
    Invest Radiol; 2011 Dec; 46(12):783-9. PubMed ID: 21808200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.